PharmaVoice

JULY 21, 2022

Both J&J and Novartis are making — or considering — big shifts in their fundamental company makeup.

246

246

Pharmacy Times

JULY 21, 2022

New state law allows dispensation of HIV meds, distribution of fentanyl test strips starting in 2023.

145

145

PharmaVoice

JULY 21, 2022

How the mRNA-based biotech is developing the first-ever prophylactic for a devastating virus.

246

246

pharmaphorum

JULY 21, 2022

Health coaching ecosystem YourCoach Health and digital therapeutics company Twill (formerly Happify Health ) are teaming up to offer access to YourCoach’s cross-specialty health coaches via Twill’s Duet platform, the companies announced today. “Digital therapy has been around for a really long time,” YourCoach Cofounder and CEO Marina Borukhovich told pharmaphorum.

137

137

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JULY 21, 2022

Individuals vaccinated simultaneously with COVID-19 booster and influenza vaccines may be more likely to experience systemic reactions and adverse health impacts.

Vaccines 132

Vaccines 132

pharmaphorum

JULY 21, 2022

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group. Schwan (pictured above) has been nominated as chair of Roche’s board of directors however, to succeed Christoph Franz will not seek re-election after more than eight years in the role, so will still be intimately involved in the company’s affairs.

119

119

Pharmaceutical Technology

JULY 21, 2022

AstraZeneca has signed a deal with the Federal Office of Public Health (FOPH) of Switzerland to deliver over 1,200 doses of antibody therapy, tixagevimab and cilgavimab combination (AZD7442), for Covid-19 prevention and treatment. Tixagevimab and cilgavimab are two long-acting antibodies (LAABs) obtained from the B-cells of patients convalescing following Covid-19.

Hospitals 105

Hospitals 105

Pharmacy Times

JULY 21, 2022

There are many changes that need to be made on multiple levels of healthcare to combat health disparities and equity.

121

121

Pharmaceutical Technology

JULY 21, 2022

Karyopharm Therapeutics has obtained new regulatory designations in the US and Europe for its investigational therapy, eltanexor (KPT-8602), to treat myelodysplastic syndromes (MDS). The company received fast-track designation from the US Food and Drug Administration (FDA) for the eltanexor development programme as a single agent to treat relapsed or refractory intermediate, high or very high-risk MDS patients.

Compounding 105

Compounding Labelling FDA 105

pharmaphorum

JULY 21, 2022

GSK’s former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called Vicebio that will go up against his former employer with a vaccine against respiratory syncytial virus (RSV) infections. The London-based company was founded by venture capital firm Medicxi in 2019, but has now come out of stealth mode with financial backing of €18 million and a platform based on a ‘molecular clamp’ technology developed by researchers at the University of Queensland (

Vaccines 105

Vaccines Immunization 105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

JULY 21, 2022

The pharma industry has deeply rooted environmental, social, and governance (ESG) issues that challenge sustainability. Overcoming these challenges requires collaborative, proactive steps to achieve sustainability goals and turn the reputation of this industry around. Listed below are the key technology trends impacting the ESG performance in the healthcare sector, as identified by GlobalData.

Hospitals 98

Hospitals FDA 98

pharmaphorum

JULY 21, 2022

While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in head and neck cancer. The PD-1 inhibitor missed the mark in the phase 3 KEYNOTE-412 trial in 780 newly-diagnosed patients with head and neck squamous cell carcinoma (HNSCC), a notoriously hard-to-treat form of cancer.

Chemotherapy 98

Chemotherapy 98

The Thyroid Pharmacist

JULY 21, 2022

In my clinical experience, I’ve seen many cases of thyroid problems go undiagnosed (or misdiagnosed) because most doctors don’t perform a comprehensive test panel. I spent almost a decade undiagnosed because I only had one marker tested. My thyroid condition was missed completely, leading me to deal with needless “mystery” symptoms like chronic fatigue, depression, anxiety, and many others, for far too long!

Dosage 75

Dosage Insurance Immunization 75

pharmaphorum

JULY 21, 2022

The pharmaceutical industry has long been highly regulated to help ensure quality and safety across all aspects of its business. However, many firms were hit hard by the pandemic and are facing ongoing challenges with supply chain and weather-related disruptions, as well as shortages of raw materials, packing materials, and active ingredients. As a result, some businesses have been forced in the last 18 months to make risk-based decisions based on the resources available to them rather than the

FDA 98

FDA Pharmaceutical Companies Pharmaceutical Companies 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 21, 2022

Approximately one-third of the individuals had an intracranial response among those with central nervous system metastases.

65

65

Pharmaceutical Technology

JULY 21, 2022

ZyVersa Therapeutics has signed a definitive business combination agreement with blank-check special purpose acquisition company (SPAC) Larkspur Health Acquisition. The deal, which will make ZyVersa a publicly traded biopharma company, values the merged entity at an estimated pro forma enterprise value of nearly $108.92m. It is expected to offer cash proceeds of up to $83.12m to ZyVersa, comprising up to nearly $77.67m of cash in the trust account of Larkspur and around $7m from private investme

59

59

Pharmacy Times

JULY 21, 2022

Findings suggest potential screening and disease detection opportunities.

65

65

The Guardian - Pharmaceutical Industry

JULY 21, 2022

Penalties come after an in-depth investigation carried out by the Competition and Markets Authority The drugmakers Pfizer and Flynn Pharma have been fined a total of £70m for overcharging the NHS for a life-saving epilepsy drug. The UK’s competition watchdog fined New York-based Pfizer £63m and imposed a £6.7m penalty on Flynn, a smaller UK pharmaceutical firm based in Stevenage.

53

53

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JULY 21, 2022

It's really been a challenge for Health Mart pharmacies with the labor market the way that it is.

65

65

Pharma Times

JULY 21, 2022

Difficult choices loom regarding which areas of patient care to cut back

Patient Care 52

Patient Care 52

Pharmacy Times

JULY 21, 2022

Poziotinib is an irreversible pan HER2 inhibitor with activity against mutations of HER1, HER2, and HER4.

65

65

The Spirit Pharmacist

JULY 21, 2022

One common question I'm asked is how the subjective experience of different psychedelic tryptamines are similar or different from one another. It's a good question because there are some pretty noticeable differences between the subjective experiences invoked by different psychedelics. There are four psychedelic tryptamines that I wanted to touch upon including the three classic psychedelic tryptamines N,N-DMT, psilocybin, and LSD as well as the naturally occurring tryptamine 5-MeO-DMT.

52

52

Pharmacy Times

JULY 21, 2022

The FDA granted the vaccine series Emergency Use Authorization on July 14, based on clinical trial data showing significant efficacy and safety.

Vaccines 65

Vaccines FDA 65

Digital Pharmacist

JULY 21, 2022

Let’s start off with, what is Mark Cuban Cost Plus Drug Company (MCCPDC ): Mark Cuban Cost Plus Drug Company (MCCPDS) was founded by Mark Cuban and Dr. Alexander Oshmyansky in January 2022. They have stated “At Mark Cuban Cost Plus Drug Company, we offer hundreds of common (and often life saving) drugs at understandable prices.” MCCPDC is able to offer low pricing because they “cut out the pharmacy middlemen and negotiate directly with manufacturers” In this blog, we will explore the differences

Independent Pharmacies 52

Independent Pharmacies Insurance Prescription Filling 52

Pharmacy Times

JULY 21, 2022

TriDerma Eczema Fast Healing helps sooth dry and irritated skin for itch relief.

65

65

Pharmaceutical Commerce

JULY 21, 2022

New property is valued at $323 million.

52

52

Pharmacy Times

JULY 21, 2022

Dronabinol (Syndros) is a cannabinoid indicated in adults for the treatment of: anorexia associated with weight loss in patients with AIDS and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

Chemotherapy 65

Chemotherapy 65

Outsourcing Pharma

JULY 21, 2022

This monthâs announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

52

52

Pharmacy Times

JULY 21, 2022

The panel explore emerging treatment pathways in HR+/HER2- breast cancer and the impacts on care management and patient outcomes.

56

56

PharmExec

JULY 21, 2022

In episode 113, Indranil Bagchi, senior vice president and worldwide head, value and access at Novartis, and member of Pharmaceutical Executive Editorial Advisory Board, discusses the challenges of reaching patients and what he believes can help improve the situation.

52

52

Pharmacy Times

JULY 21, 2022

Heather N. Moore, PharmD, BCOP, CPP, drives a discussion on the role of pharmacists in treatment strategy and optimizing patient adherence to HR+/HER2- breast cancer treatment.

56

56

Outsourcing Pharma

JULY 21, 2022

The research institutions are joining on a community-based collaborative initiative to work toward greater study inclusion, supported by funding from PhRMA.

52

52

pharmaphorum

JULY 21, 2022

Merck & Co has signed a deal with digital health firm Hyfe that will see its cough-detecting smartphone app offered to patients in the US. Hyfe’s app uses artificial intelligence to monitor coughing patterns by recording factors like volume, frequency, amplitude and context whilst running in the background on an iOS or Android device. The app attracted a lot of attention during the pandemic as a potentially way to differentiate COVID-19 from other respiratory infections, but Merck says

FDA 52

FDA 52